glp-1 obesity drug market forecast 2030 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 GLP-1 Market Industry Trends and
Description
Hopefully, in a few years, we will have a lot more data to answer experts most pressing questions around GLP-1s and mental health
While the intraluminal delivery of bile acids stimulated GIP secretion in rats [62], chenodeoxycholic acid (CDCA), one of the primary bile acids and an agonist of G-protein-coupled bile acid receptor-1 (GPBAR-1), attenuated rather than enhanced postprandial GIP secretion in human subjects [63]
Here is a nice comparison table and some nuggets to think about
2025;19(4):jjae160
Published research cited in this article White CM, Tai Z, Nuzi K
